In the context of tumor cells, it was shown to work as a chromatin modifier through the recruitment of EZH2 to the promoter of target genes [4], as a competing endogenous RNA, sponging let-7 [5, 6], and also as the precursor for miR-675, in turn involved in tumorigenesis [7–12]. Here, EZH2 is linked to neoplasm.